TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Nobel Biocare AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
345,411
|
426,637
|
376,622 |
| Financial expenses |
21,174
|
9,966
|
19,101 |
| Earnings before taxes |
15,538
|
18,580
|
22,807 |
| EBITDA |
51,720
|
54,863
|
67,491 |
| Total assets |
1,148,628
|
1,131,739
|
948,609 |
| Current assets |
531,683
|
464,508
|
256,678 |
| Current liabilities |
334,846
|
304,070
|
142,111 |
| Equity capital |
801,672
|
816,517
|
797,562 |
| - share capital |
205,999
|
213,046
|
211,954 |
| Employees (average) |
370
|
345
|
364 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
69.8%
|
72.1%
|
84.1% |
| Turnover per employee |
934
|
1,237
|
1,035 |
| Profit as a percentage of turnover |
4.5%
|
4.4%
|
6.1% |
| Return on assets (ROA) |
3.2%
|
2.5%
|
4.4% |
| Current ratio |
158.8%
|
152.8%
|
180.6% |
| Return on equity (ROE) |
1.9%
|
2.3%
|
2.9% |
| Change turnover |
-67,114
|
48,075
|
47,758 |
| Change turnover % |
-16%
|
13%
|
15% |
| Chg. No. of employees |
25
|
-19
|
14 |
| Chg. No. of employees % |
7%
|
-5%
|
4% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.